|Bid||1.7000 x 1000|
|Ask||1.7100 x 900|
|Day's range||1.6800 - 1.8300|
|52-week range||1.2900 - 3.6500|
|Beta (5Y monthly)||1.51|
|PE ratio (TTM)||N/A|
|Earnings date||02 May 2023 - 08 May 2023|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||31 Oct 2014|
|1y target est||17.50|
Paratek (PRTK) delivered earnings and revenue surprises of -1,300% and 33.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
With the business potentially at an important milestone, we thought we'd take a closer look at Paratek Pharmaceuticals...
If you want to know who really controls Paratek Pharmaceuticals, Inc. ( NASDAQ:PRTK ), then you'll have to look at the...